Travere Therapeutics (TVTX) Change in Taxes (2015 - 2022)
Travere Therapeutics posted quarterly Change in Taxes of -$22000.0 for Q4 2022, up 76.34% year-on-year from -$12475.6 in Q4 2021, and down 108.33% on a QoQ basis from $264000.0 in Q3 2022.
Travere Therapeutics (TVTX) has 7 years of Change in Taxes data on file, last reported at -$22000.0 in Q4 2022.
- For the quarter ending Q4 2022, Change in Taxes rose 76.34% year-over-year to -$22000.0; the trailing twelve-month figure through Dec 2022 stood at $154000.0 (up 100.9% YoY), and the FY2025 full-year result was -$849000.0, down 2170.73% from the prior year.
- Change in Taxes for Q4 2022 stood at -$22000.0, down from $264000.0 in the prior quarter.
- Across five years, Change in Taxes topped out at $18.8 million in Q1 2020 and bottomed at -$16.8 million in Q2 2021.
- The 4-year median for Change in Taxes is -$74000.0 (2020), against an average of -$128153.8.
- The widest annual swing landed in 2020, when Change in Taxes jumped 6280.26%; it then tumbled 22566.22% in 2021.
- A 4-year view of Change in Taxes shows it stood at -$555000.0 in 2019, then surged by 735.32% to $3.5 million in 2020, then slumped by 102.64% to -$93000.0 in 2021, then jumped by 76.34% to -$22000.0 in 2022.
- The last three Change in Taxes figures came in at -$22000.0 (Q4 2022), $264000.0 (Q3 2022), and -$93000.0 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -22,000.00 |
| Dec 31, 2022 | -22,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Dec 31, 2021 | -93,000.00 |
| Dec 31, 2021 | -93,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -16.77 Mn |
| Jun 30, 2021 | -16.77 Mn |
| Mar 31, 2021 | -238,000.00 |
| Mar 31, 2021 | -238,000.00 |
| Dec 31, 2020 | 3.53 Mn |
| Dec 31, 2020 | 3.53 Mn |
| Sep 30, 2020 | -6.49 Mn |
| Sep 30, 2020 | -6.49 Mn |
| Jun 30, 2020 | -74,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Mar 31, 2020 | 18.79 Mn |
| Mar 31, 2020 | 18.79 Mn |
| Dec 31, 2019 | -555,000.00 |
| Dec 31, 2019 | -555,000.00 |
| Jun 30, 2019 | 304,000.00 |
| Jun 30, 2019 | 304,000.00 |
| Mar 31, 2019 | -304,000.00 |
| Mar 31, 2019 | -304,000.00 |
| Mar 31, 2017 | -181,000.00 |
| Mar 31, 2017 | -181,000.00 |
| Dec 31, 2016 | -8.52 Mn |
| Dec 31, 2016 | -8.52 Mn |
| Dec 31, 2015 | -1.52 Mn |
| Dec 31, 2015 | -1.52 Mn |